Related Experiment Video
Updated: Jun 29, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media
Jun Shimada1, Sung K Moon, Haa-Yung Lee
1Gonda Department of Cell and Molecular Biology, House Ear Institute, Los Angeles, CA, USA. Jasmd513@aol.com
Background:
Lysozyme is an antimicrobial innate immune molecule degrading peptidoglycan of the bacterial cell wall. Lysozyme shows the ubiquitous expression in wide varieties of species and tissues including the tubotympanum of mammals. We aim to investigate the effects of lysozyme depletion on pneumococcal clearance from the middle ear cavity.
Methods:
Immunohistochemistry was performed to localize lysozyme in the Eustachian tube. Lysozyme expression was compared between the wild type and the lysozyme M-/- mice using real time quantitative RT-PCR and western blotting. Muramidase activity and bactericidal activity of lysozyme was measured using a lysoplate radial diffusion assay and a liquid broth assay, respectively. To determine if depletion of lysozyme M increases a susceptibility to pneumococal otitis media, 50 CFU of S. pneumoniae 6B were transtympanically inoculated to the middle ear and viable bacteria were counted at day 3 and 7 with clinical grading of middle ear inflammation.
Results:
Immunolabeling revealed that localization of lysozyme M and lysozyme P is specific to some/particular cell types of the Eustachian tube. Lysozyme P of lysozyme M-/- mice was mainly expressed in the submucosal gland but not in the tubal epithelium. Although lysozyme M-/- mice showed compensatory up-regulation of lysozyme P, lysozyme M depletion resulted in a decrease in both muramidase and antimicrobial activities. Deficiency in lysozyme M led to an increased susceptibility to middle ear infection with S. pneumoniae 6B and resulted in severe middle ear inflammation, compared to wild type mice.
Conclusion:
The results suggest that lysozyme M plays an important role in protecting the middle ear from invading pathogens, particularly in the early phase. We suggest a possibility of the exogenous lysozyme as an adjuvant therapeutic agent for otitis media, but further studies are necessary.
Insights
Lysozyme M is crucial for clearing pneumococcal infections in the middle ear. Its depletion increases susceptibility to otitis media and inflammation, suggesting potential therapeutic uses.
Area of Science:
- Immunology
- Microbiology
- Otolaryngology
Background:
- Lysozyme is a key innate immune molecule that degrades bacterial cell walls.
- It is widely expressed in various species and tissues, including the mammalian middle ear.
- The role of lysozyme in middle ear infections, specifically otitis media, requires further investigation.
Purpose of the Study:
- To investigate the impact of lysozyme M depletion on the clearance of Streptococcus pneumoniae from the middle ear.
- To assess the susceptibility of lysozyme M-deficient mice to pneumococcal otitis media.
- To evaluate the expression and activity of lysozyme in the Eustachian tube.
Main Methods:
- Immunohistochemistry to localize lysozyme M and P in the Eustachian tube.
- Real-time quantitative RT-PCR and Western blotting to compare lysozyme expression in wild-type and lysozyme M-/- mice.
- Muramidase and bactericidal activity assays to measure lysozyme function.
- Transtympanic inoculation of S. pneumoniae to assess middle ear infection and inflammation.
Main Results:
- Lysozyme M and P exhibit specific localization within the Eustachian tube.
- Lysozyme M deficiency leads to compensatory upregulation of lysozyme P but decreased overall lysozyme activity.
- Lysozyme M-deficient mice show increased susceptibility to S. pneumoniae infection, resulting in more severe middle ear inflammation.
Conclusions:
- Lysozyme M plays a critical role in early-phase protection against middle ear pathogens.
- Depletion of lysozyme M compromises the middle ear's defense against pneumococcal infection.
- Exogenous lysozyme may hold potential as an adjuvant therapy for otitis media.
Related Concept Videos
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Lysosomal Hydrolases
Bacterial Meningitis II: Pathophysiology
Streptococcal Pharyngitis
Formation of Lipopolysaccharides
